Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

8.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 19.50
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 21,788
  • Market Cap: £15.19m
  • RiskGrade: 348
  • Beta: 0.04

Regulatory News

First use of KidneyIntelX in new CKD therapy trial 20-May-2025 07:00 RNS
Holding(s) in Company 16-May-2025 15:10 RNS
Holding(s) in Company 29-Apr-2025 11:03 RNS
Holding(s) in Company 22-Apr-2025 12:47 RNS
Holding(s) in Company 17-Apr-2025 14:56 RNS
Holding(s) in Company 17-Apr-2025 07:00 RNS
Late Breaking KidneyIntelX data show care impact 16-Apr-2025 07:00 RNS
Q3 Trading Update 10-Apr-2025 07:00 RNS
Holding(s) in Company 09-Apr-2025 13:58 RNS
Holding(s) in Company 07-Apr-2025 11:33 RNS
Holding(s) in Company 31-Mar-2025 13:21 RNS
Holding(s) in Company 25-Mar-2025 14:59 RNS
Holding(s) in Company 21-Mar-2025 13:34 RNS
Holding(s) in Company 20-Mar-2025 16:19 RNS
Half-year Report 18-Mar-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 8.00p
Change Today -0.25p
% Change -3.03 %
52 Week High 19.50
52 Week Low 6.75
Volume 21,788
Shares Issued 189.93m
Market Cap £15.19m
Beta 0.04
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.06% above the market average17.06% above the market average17.06% above the market average17.06% above the market average17.06% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
Price Trend
60.5% below the market average60.5% below the market average60.5% below the market average60.5% below the market average60.5% below the market average
45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average
Income Not Available
Growth
30.99% below the market average30.99% below the market average30.99% below the market average30.99% below the market average30.99% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

RENX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page